Fibralign won the prestigious Medtech Innovator award at the 2014 WSGRC Medical Device Conference, placing first out of over 700 leading MedTech startups for this top honor and $125,000 prize.
MedTech Innovator (MTI) is the world’s largest accelerator for medical device, digital health, and diagnostic companies. MTI’s mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system.
Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology (ISL), which was held 15-19 October 2025 in Antalya, Turkey. As part of this session, Dr. Corrado...
Fibralign Corp. and its South Korean distributor Healing Solutions, LTD announced today that Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema. Good Moonhwa is the first medical center in Asia and second worldwide to...
Terumo Corporation announced that the first clinical trial conducted in Japan for evaluation the BioBridge® Collagen Matrix in the surgical treatment of lymphedema has reached its endpoint. Terumo is managing and funding clinical studies in Japan which are being used...